Device Trial Radar · NCT07004439
A Post-market Registry to Assess Safety and Performance of RefluxStop™ in the Treatment of GERD in General Hospital Practice
Last checked: Nov 19, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Not yet recruiting
Enrollment
500
Planned (sponsor's estimate)
Start
Sep 15, 2025
Primary completion
Aug 1, 2029
Study completion Aug 1, 2035
Sponsor
- Lead sponsor
- Implantica CE Reflux Ltd.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Jun 4, 2025
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A post-market retrospective and prospective, open label, multicenter, single-arm registry study using standard clinical procedures to record available and/or new data to evaluate the safety and performance of RefluxStop™ for the treatment of subjects suffering from GERD. Following surgery, patients will have follow-ups visits at 3 and 6 months and annually up to 7 years.
Conditions
- Gastroesophageal Reflux Disease
Interventions
RefluxStop™ implantationDevice
Standard surgical technique for implantation RefluxStop™, as described in the Instructions for Use
Primary outcomes
What the sponsor says the trial is designed to measure.
- Reduction of Patient Reported Outcome - Side effects (PROS)Time frame: 1 year
Locations
5 sites in 2 countries. Site status is shown where the registry gives one.
Klinikum Friedrichshafen GmbH
Friedrichshafen, Germany
H. La Mancha Centro
Alcázar de San Juan, Spain
H. Infanta Sofía
Madrid, Spain
2 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.